Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Patterns of ANA+ B cells for SLE patient stratification
Jolien Suurmond, Yemil Atisha-Fregoso, Ashley N. Barlev, Silvia A. Calderon, Meggan C. Mackay, Cynthia Aranow, Betty Diamond
Jolien Suurmond, Yemil Atisha-Fregoso, Ashley N. Barlev, Silvia A. Calderon, Meggan C. Mackay, Cynthia Aranow, Betty Diamond
View: Text | PDF
Research Article Immunology

Patterns of ANA+ B cells for SLE patient stratification

  • Text
  • PDF
Abstract

IgG antinuclear antibodies (ANAs) are a dominant feature of several autoimmune diseases. We previously showed that systemic lupus erythematosus (SLE) is characterized by increased ANA+ IgG plasmablasts/plasma cells (PCs) through aberrant IgG PC differentiation rather than an antigen-specific tolerance defect. Here, we aimed to understand the differentiation pathways resulting in ANA+ IgG PCs in SLE patients. We demonstrate distinct profiles of ANA+ antigen-experienced B cells in SLE patients, characterized by either a high frequency of PCs or a high frequency of IgG+ memory B cells. This classification of SLE patients was unrelated to disease activity and remained stable over time in almost all patients, suggesting minimal influence of disease activity. A similar classification applies to antigen-specific B cell subsets in mice following primary immunization with T-independent and T-dependent antigens as well as in lupus-prone mouse models (MRL/lpr and NZB/W). We further show that, in both lupus-prone mice and SLE patients, the classification correlates with the serum autoantibody profile. In this study, we identified B cell phenotypes that we propose reflect an extrafollicular pathway for PC differentiation or a germinal center pathway, respectively. The classification we propose can be used to stratify patients for longitudinal studies and clinical trials.

Authors

Jolien Suurmond, Yemil Atisha-Fregoso, Ashley N. Barlev, Silvia A. Calderon, Meggan C. Mackay, Cynthia Aranow, Betty Diamond

×

Figure 2

Stability of clustering over time.

Options: View larger image (or click on image) Download as PowerPoint
Stability of clustering over time.
SLE patients were classified as descr...
SLE patients were classified as described in Figure 1, and a follow-up was done between 1 month and 1 year. (A) Relative proportion of ANA+ IgG memory B cells and ANA+ IgM and IgG PCs in healthy controls and SLE patients. The SLEDAI scores at the time of each measurement are shown below each circle. Patients indicated in red had a change in classification between the first and second assessment. (B) Principal component analysis as in Figure 1, including all initial measurements for healthy subjects and patients, was used to predict the follow-up measurements in each patient. Individual dots represent only those patients with a follow-up measurement. Arrows indicate the follow-up measurement. Dotted black arrows indicate 2 patients (SLE 19 and SLE 23) for whom the classification based on the proportions in A changed over time. ANA, antinuclear antibody; HC, healthy control; PC, plasmablast/plasma cell; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts